Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Complicated Skin and Skin Structure Infections”

72 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 72 results

Post-approval studies (Phase 4)Study completedNCT01626560
What this trial is testing

The Effects of Daptomycin and Cytokines Production in Comparison With Vancomycin

Who this might be right for
Cellulitis
Hospital Universitario Evangelico de Curitiba 20
Large-scale testing (Phase 3)Study completedNCT01499277
What this trial is testing

Evaluation of Ceftaroline Fosamil Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections

Who this might be right for
Complicated Skin and Soft Tissue Infection
Pfizer 802
Large-scale testing (Phase 3)Study completedNCT00091819
What this trial is testing

Comparison of Telavancin and Vancomycin for Complicated Skin and Skin Structure Infections With a Focus on Methicillin-resistant Staphylococcus Aureus

Who this might be right for
Staphylococcal Skin Infection
Cumberland Pharmaceuticals 862
Large-scale testing (Phase 3)Study completedNCT00228410
What this trial is testing

Study Comparing Tigecycline and Vancomycin With Aztreonam in Complicated Skin and Skin Structure Infections

Who this might be right for
Skin Diseases, Infectious
Wyeth is now a wholly owned subsidiary of Pfizer 503
Large-scale testing (Phase 3)Not Yet RecruitingNCT06695143
What this trial is testing

Antimicrobial Adjuvants to Revert the Imbalance of Skin Microbiota for Improved Outcomes of Complicated Cutaneous Leishmaniasis Treatment in Ethiopia

Who this might be right for
Leishmaniasis, Cutaneous
Institute of Tropical Medicine, Belgium 180
Large-scale testing (Phase 3)WithdrawnNCT00911573
What this trial is testing

Study Evaluating Tigecycline Versus Clindamycin Or Vancomycin On Complicated Skin And Skin Structure Infections Including Those Due To Methicillin-Resistant Staphylococcus Aureus (MRSA) In Pediatric Subjects

Who this might be right for
Skin DiseasesInfection
Wyeth is now a wholly owned subsidiary of Pfizer
Testing effectiveness (Phase 2)Study completedNCT00633152
What this trial is testing

Efficacy and Safety of Ceftaroline Versus Linezolid in Subjects With Complicated Skin and Skin Structure Infections

Who this might be right for
Bacterial Infection
Forest Laboratories 150
Testing effectiveness (Phase 2)Study completedNCT01128530
What this trial is testing

Efficacy and Safety Study of JNJ-32729463 for Treating Complicated Skin and Skin Structure Infections Compared to Linezolid (Zyvox)

Who this might be right for
Complicated Skin and Skin Structure Infections
Furiex Pharmaceuticals, Inc 161
Not applicableStudy completedNCT01293435
What this trial is testing

Study Evaluating Management of Patients With Community-Acquired Pneumonia (CAP) or Complicated Skin Infections

Who this might be right for
Community Acquired Pneumonia (CAP)Complicated Skin and Skin Structures Infections (cSSSI)
AstraZeneca 4,035
Post-approval studies (Phase 4)Ended earlyNCT00102947
What this trial is testing

Daptomycin in the Treatment of Patients With Renal Insufficiency and Complicated Skin and Skin Structure Infections

Who this might be right for
Soft Tissue Infections
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 72
Testing effectiveness (Phase 2)Ended earlyNCT01494350
What this trial is testing

WR 279,396 Open Label Treatment Protocol in Tunisia

Who this might be right for
Cutaneous Leishmaniasis
U.S. Army Medical Research and Development Command 50
Not applicableStudy completedNCT00683332
What this trial is testing

Post-Marketing Study Of The Safety Of Tygacil (Tigecycline)

Who this might be right for
Complicated Skin and Skin Structure InfectionsComplicated Intra-abdominal Infections
Pfizer 621
Post-approval studies (Phase 4)Study completedNCT00711802
What this trial is testing

Safety and Efficacy Study of Daptomycin in Pediatric Participants (1 to 17 Years-old) With Skin and Skin Structure Infections

Who this might be right for
Skin Diseases, Infectious
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 396
Testing effectiveness (Phase 2)Study completedNCT00451386
What this trial is testing

Ertapenem Study in Pediatric Patients Who Have Urinary Tract Infections, Skin Infections or Community-acquired Pneumonia (0826-036)

Who this might be right for
Urinary Tract InfectionsBacterial PneumoniaSoft Tissue Infections
Merck Sharp & Dohme LLC 400
Post-approval studies (Phase 4)Study completedNCT00488761
What this trial is testing

Study Evaluating the Safety and Efficacy of Tigecycline in Hospitalized Patients With cSSSI

Who this might be right for
Skin Diseases, Infectious
Wyeth is now a wholly owned subsidiary of Pfizer 50
Post-approval studies (Phase 4)Study completedNCT00368537
What this trial is testing

Study Comparing the Safety and Efficacy of Tigecycline With Ampicillin-Sulbactam or Amoxicillin-Clavulanate to Treat Skin Infections

Who this might be right for
Skin Diseases, Bacterial
Wyeth is now a wholly owned subsidiary of Pfizer 550
Post-approval studies (Phase 4)Ended earlyNCT01175707
What this trial is testing

Study Comparing Cubicin With Vancomycin in Treatment of Participants With Complicated Skin and Skin Structure Infections in a Home Infusion Setting

Who this might be right for
Complicated Skin or Skin Structure Infection
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 80
Not applicableStudy completedNCT00827541
What this trial is testing

Post-Authorization Study Evaluating Safety Of Tigecycline

Who this might be right for
Intra-Abdominal InfectionsSkin Disease, InfectiousSoft Tissues Infections
Pfizer 115
Testing effectiveness (Phase 2)Study completedNCT00077675
What this trial is testing

Phase 2 Trial of TD-6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI)

Who this might be right for
Infections, Gram-positive Bacterial
Cumberland Pharmaceuticals 201
Not applicableStudy completedNCT04198571
What this trial is testing

Retrospective Chart Review Study to Assess Characteristics, Treatment Outcomes and Resource Use of Adults Hospitalized for CAP and CSSTi Treated With Zinforo in Multiple Countries

Who this might be right for
Community Acquired PneumoniaComplicated Skin and Soft Tissue Infection
Pfizer 317
Load More Results